Strong staining of KRAS (the KRAS mutation commonly had strong staining) in the tumor cell nuclei was significantly associated with FIGO stage (P = 0.011), tumor type (P = 0.025) and WHO grade (P = 0.027). The gene discussed is KRAS; the disease is neoplasm.